JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vilner, B. J.
Right arrow Articles by Bowen, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vilner, B. J.
Right arrow Articles by Bowen, W. D.

Vol. 292, Issue 3, 900-911, March 2000

Modulation of Cellular Calcium by Sigma-2 Receptors: Release from Intracellular Stores in Human SK-N-SH Neuroblastoma Cells

Bertold J. Vilner and Wayne D. Bowen

Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

Human SK-N-SH neuroblastoma cells expressed sigma-1 and sigma-2 receptors with similar pharmacological profiles to those of rodent-derived tissues, although sigma-2 receptors exhibited some affinity differences that might suggest heterogeneity or species differences. Structurally diverse sigma ligands produced two types of increases in intracellular (cytosolic) Ca2+ concentration ([Ca2+]i) in these cells. CB-64D, CB-64L, JL-II-147, BD737, LR172, BD1008, haloperidol, reduced haloperidol, and ibogaine all produced an immediate, dose-dependent, and transient rise in [Ca2+]i. Sigma-inactive compounds structurally similar to the most active sigma ligands and ligands for several neurotransmitter receptors produced little or no effect. The high activity of CB-64D and ibogaine (sigma-2-selective ligands) compared with the low activity of (+)-pentazocine and other (+)-benzomorphans (sigma-1-selective ligands), in addition to enantioselectivity for CB-64D over CB-64L, strongly indicated mediation by sigma-2 receptors. The effect of CB-64D and BD737 was blocked by the sigma antagonists BD1047 and BD1063, further confirming specificity as a receptor-mediated event. The transient rise in [Ca2+]i occurred in the absence of extracellular Ca2+ and was completely eliminated by pretreatment of cells with thapsigargin. Thus, sigma-2 receptors stimulate a transient release of Ca2+ from the endoplasmic reticulum. Prolonged exposure of cells to sigma-receptor ligands resulted in a latent and sustained rise in [Ca2+]i, with a pharmacological profile identical to that of the transient rise. This sustained rise in [Ca2+]i was affected by neither the removal of extracellular Ca2+ nor thapsigargin pretreatment, suggesting latent sigma-2 receptor-induced release from thapsigargin-insensitive intracellular Ca2+ stores. Sigma-2 receptors may use Ca2+ signals in producing cellular effects.

0022-3565/00/2923-0900$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by U.S. Government


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Herrera, C. Katnik, J. D. Rodriguez, A. A. Hall, A. Willing, K. R. Pennypacker, and J. Cuevas
{sigma}-1 Receptor Modulation of Acid-Sensing Ion Channel a (ASIC1a) and ASIC1a-Induced Ca2+ Influx in Rat Cortical Neurons
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 491 - 502.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. T. Tchedre, R.-Q. Huang, A. Dibas, R. R. Krishnamoorthy, G. H. Dillon, and T. Yorio
Sigma-1 Receptor Regulation of Voltage-Gated Calcium Channels Involves a Direct Interaction
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4993 - 5002.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Wu and W. D. Bowen
Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation: CONSTITUTIVE ENHANCEMENT OF CALCIUM SIGNALING IN MCF-7 TUMOR CELLS
J. Biol. Chem., October 17, 2008; 283(42): 28198 - 28215.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Zeng, S. Vangveravong, J. Xu, K. C. Chang, R. S. Hotchkiss, K. T. Wheeler, D. Shen, Z.-P. Zhuang, H. F. Kung, and R. H. Mach
Subcellular Localization of Sigma-2 Receptors in Breast Cancer Cells Using Two-Photon and Confocal Microscopy
Cancer Res., July 15, 2007; 67(14): 6708 - 6716.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Katnik, W. R. Guerrero, K. R. Pennypacker, Y. Herrera, and J. Cuevas
Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1355 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Azzariti, N. A. Colabufo, F. Berardi, L. Porcelli, M. Niso, G. M. Simone, R. Perrone, and A. Paradiso
Cyclohexylpiperazine derivative PB28, a {sigma}2 agonist and {sigma}1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.
Mol. Cancer Ther., July 1, 2006; 5(7): 1807 - 1816.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. S. Ostenfeld, N. Fehrenbacher, M. Hoyer-Hansen, C. Thomsen, T. Farkas, and M. Jaattela
Effective Tumor Cell Death by {sigma}-2 Receptor Ligand Siramesine Involves Lysosomal Leakage and Oxidative Stress
Cancer Res., October 1, 2005; 65(19): 8975 - 8983.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Xu and T. L. Krukoff
Adrenomedullin Stimulates Nitric Oxide Release from SK-N-SH Human Neuroblastoma Cells by Modulating Intracellular Calcium Mobilization
Endocrinology, May 1, 2005; 146(5): 2295 - 2305.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Mukherjee, T. K. Prasad, N. M. Rao, and R. Banerjee
Haloperidol-associated Stealth Liposomes: A POTENT CARRIER FOR DELIVERING GENES TO HUMAN BREAST CANCER CELLS
J. Biol. Chem., April 22, 2005; 280(16): 15619 - 15627.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Aydar, C. P. Palmer, and M. B. A. Djamgoz
Sigma Receptors and Cancer: Possible Involvement of Ion Channels
Cancer Res., August 1, 2004; 64(15): 5029 - 5035.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. A. Spruce, L. A. Campbell, N. McTavish, M. A. Cooper, M. V. L. Appleyard, M. O'Neill, J. Howie, J. Samson, S. Watt, K. Murray, et al.
Small Molecule Antagonists of the {sigma}-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth in Vitro and in Vivo
Cancer Res., July 15, 2004; 64(14): 4875 - 4886.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. P. Monnet, M. P. Morin-Surun, J. Leger, and L. Combettes
Protein Kinase C-Dependent Potentiation of Intracellular Calcium Influx by {sigma}1 Receptor Agonists in Rat Hippocampal Neurons
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 705 - 712.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. J. Nuwayhid and L. L. Werling
Steroids Modulate N-Methyl-D-aspartate-Stimulated [3H]Dopamine Release from Rat Striatum via {sigma} Receptors
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 934 - 940.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. J. Nuwayhid and L. L. Werling
sigma 1 Receptor Agonist-Mediated Regulation of N-Methyl-D-aspartate-Stimulated [3H]Dopamine Release Is Dependent upon Protein Kinase C
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 364 - 369.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. A. Meyer, M. Carta, L. D. Partridge, D. F. Covey, and C. F. Valenzuela
Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons. POSSIBLE ROLE OF METABOTROPIC sigma 1-LIKE RECEPTORS
J. Biol. Chem., August 2, 2002; 277(32): 28725 - 28732.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. E. Bertolesi, C. Shi, L. Elbaum, C. Jollimore, G. Rozenberg, S. Barnes, and M. E. M. Kelly
The Ca2+ Channel Antagonists Mibefradil and Pimozide Inhibit Cell Growth via Different Cytotoxic Mechanisms
Mol. Pharmacol., August 1, 2002; 62(2): 210 - 219.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
H. Zhang and J. Cuevas
Sigma Receptors Inhibit High-Voltage-Activated Calcium Channels in Rat Sympathetic and Parasympathetic Neurons
J Neurophysiol, June 1, 2002; 87(6): 2867 - 2879.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. E. Derbez, R. M. Mody, and L. L. Werling
sigma 2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 306 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. W. Crawford and W. D. Bowen
Sigma-2 Receptor Agonists Activate a Novel Apoptotic Pathway and Potentiate Antineoplastic Drugs in Breast Tumor Cell Lines
Cancer Res., January 1, 2002; 62(1): 313 - 322.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.